46 results
Page 2 of 3
424B5
0sflt 4dbq
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.2
2w41y
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
crx5cs42m
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
7ko0a
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
x9x q3c8y
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
4sabhnohm 7xr
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
0ushh6vcf4iv qlmp
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.1
8t2r3ic
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
xhkus3arz1jvjxzfu
14 Jun 21
Other Events
5:21pm
8-K
EX-99.1
i2j95wht
18 May 21
Other Events
3:09pm
8-K
EX-99.1
ddls595x3y
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-99.2
rnhtlhds
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
EX-99.2
223o0zj
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
EX-99.1
0u1jlf1l6f4
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K
EX-99.1
filwz4j80aj
3 Jun 20
Regulation FD Disclosure
12:00am